Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
17 Mar 2021
Amplia Completes Single Dose Study of AMP945
17 Feb 2021
Amplia Initiates Multiple Dose Study of AMP945
16 Feb 2021
Appendix 2A - Exercise of Options
11 Feb 2021
Investor Update - February 2021
28 Jan 2021
Quarterly Activities and Cashflow Reports - Dec 2020 Qtr
11 Jan 2021
Appendix 2A - Exercise of Options
Previous
1
2
3
4
5
6
7
8
9
